Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.
Simon R ProcterBronner P GonçalvesProma PaulJaya ChandnaFarah SeedatArtemis KoukounariRaymond C W HutubessyCaroline TrotterJoy E LawnMark JitPublished in: PLoS medicine (2023)
In this study, we found that maternal GBS vaccination could have a large impact on infant morbidity and mortality. Globally, a GBS maternal vaccine at reasonable prices is likely to be a cost-effective intervention.